Federal Register / Vol. 65, No. 100 / Tuesday, May 23, 2000 / Notices 33335

Type of respondents Number of

respondents

Frequency

of response

Estimated

average response time

Estimated

annual burden hours

Patients/Family ................................................................................................................ 3,600 1.00 0.167 600

Phys. Asst ........................................................................................................................ 7,200 1.00 0.167 1,200

Physicians ........................................................................................................................ 1,200 1.00 0.167 200

Totals ........................................................................................................................ 12,000 2,000

The annual reporting burden is as

follows:

Estimated Number of Respondents:

12,000.

Estimated Number of Responses per

Respondent: 1.

Estimated Average Burden Hours per

Response: 01671.

Estimated Total Annual Burden Hours

Requested: 2,000.

The annualized cost to respondents is

estimated at $39,000. There are no

Capital Costs to report. There are no

Operating or Maintenance Costs to

report.

Request for Comments

Written comments and/or

suggestionns from the public and

affected agencies are invited on one or

more of the following points: (1)

Whether the proposed collection of

information is necessary for the proper

performance of the function of the

agency, including whether the

information will have practical utility;

(2) the accuracy of the agency’s estimate

of the burden of the proposed collection

of information, including the validity of

the methodology and assumptions used;

(3) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (4) ways to minimize the

burden of the collection of information

on those who are to respond, including

the use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology.

Please address all comments

concerning the proposed collection to

Kathy Kranzfelder, Project Officer,

NIDDK Information Clearinghouses,

NIH, Building 31, Room 9A04,

MSC2560, Bethesda, MD 20852. You

may also submit comment and data by

electronic mail (e-mail) at:

<kranzfeldk@hq.niddk.nih.gov>.

Comments Due Date

Comments regarding this information

are best assured of having their full

effect if received within 60 days

following the date of this notice.

FOR FURTHER INFORMATION: To request

more information on the proposed

project, contact Kathy Kranzfelder at

301–496–3583 or via e-mail at:

<Kranzfeldk@hq.niddk,nih.gov>.

Dated: May 8, 2000.

Earl L. Laurence,

Department Director, NIDDK.

[FR Doc. 00–12907 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Notice of Meeting: DHHS Chronic

Fatigue Syndrome Coordinating

Committee

In accordance with section 10(a) of

the Federal Advisory Committee Act, as

amended (5 U.S.C., Appendix 2), notice

is hereby given of a meeting of the

DHHS Chronic Fatigue Syndrome

Coordinating Committee.

Name: Department of Health and Human

Services (DHHS) Chronic Fatigue Syndrome

Coordinating Committee (CFSCC).

Time and Date: Wednesday, July 12, 2000,

from 9 a.m. to 3:30 p.m.

Place: Hubert H. Humphrey Building,

Room 800, 200 Independence Avenue, SW,

Washington, DC 20201.

Status: Open to the public, limited only by

the space available. The meeting room will

accommodate approximately 100 people.

Individuals who plan to attend and need

special assistance, such as sign language

interpretation or other reasonable

accommodations, should notify the Contact

Person listed below in advance of the

meeting.

Notice: In the interest of security, the

Department has instituted stringent

procedures for entrance to the Hubert H.

Humphrey Building by non-government

employees. Thus, persons without a

government identification card will need to

provide a photo ID and must know the

subject and room number of the meeting in

order to be admitted into the building.

Visitors must use the Independence Avenue

entrance.

Purpose: The Committee is charged with

providing advice to the Secretary, the

Assistant Secretary for Health, and the

Commissioner, Social Security

Administration (SSA), to assure interagency

coordination and communication regarding

chronic fatigue syndrome (CFS) research and

other related issues; facilitating increased

DHHS and agency awareness of CFS research

and educational needs; developing

complementary research programs that

minimize overlap; identifying opportunities

for collaborative and/or coordinated efforts in

research and educational; and developing

informed responses to constituency groups

regarding DHHS and SSA efforts and

progress.

Matters To Be Discussed: The meeting will

have, as its sole focus, a discussion of the

forthcoming General Accounting Office

report on CFS research activities at NIH and

CDC and the role of the DHHS CFSCC.

Because this is a briefing session, there will

be no public testimony.

Contact Person for More Information:

Janice C. Ramsden, Executive Secretary,

CFSCC, Office of the Acting Director, NIH,

Building 1, Room 235, 1 Center Drive, MSC

0159, Bethesda, Maryland 20892–0159, email jr52h@nih.gov or telephone 301–496–

0959.

Dated: May 16, 2000.

LaVerne Stringfield,

Director, Office of Advisory Committee Policy.

[FR Doc. 00–12898 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Initial Review Group Subcommittee

G—Education.

Date: June 27–29, 2000.

Time: 1 p.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

33336 Federal Register / Vol. 65, No. 100 / Tuesday, May 23, 2000 / Notices

Place: Georgetown Holiday Inn, 2101

Wisconsin Avenue, NW, Washington, DC

20007.

Contact Person: Harvey P. Stein, Phd,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, National

Institutes of Health, 6116 Executive

Boulevard, Room 8036, Bethesda, MD 20892,

301/496–7481.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.3398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 16, 2000.

LaVerene Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12892 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

President’s Cancer Panel.

The meeting will be open to the

public, with attendance limited to space

available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

Name of Committee: President’s Cancer

Panel.

Date: June 15–16, 2000.

Time: 8:30 a.m. to 5 p.m.

Agenda: Improving Cancer Care for All:

Real People—Real Problems.

Place: Doubletree Hotel, Omaha, NE.

Contact Person: Maureen O. Wilson, Phd,

Executive Secretary, National Cancer

Institute, National Institutes of Health, 31

Center Drive, Building 31, Room 4A48,

Bethesda, MD 20892, 301/496–1148.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 16, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12893 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel, Spores for

Breast and Prostate Cancer.

Date: June 13–15, 2000.

Time: 8 a.m. to 6 p.m.

Agenda: To review and evaluate grant

applications.

Place: Doubletree Hotel Park Terrace on

Embassy Row, 1515 Rhode Island Avenue,

NW, Washington, DC 20005.

Contact Person: Brian E. Wojcik, Phd,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, 6116

Executive Boulevard, Room 8019, Bethesda,

MD 20892, 301–402–2785.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction;

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 16, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12894 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Special Emphasis Panel,

Determining the Carcinogenic Significance of

Heterocyclic Amines.

Date: June 12–14, 2000.

Time: 7 pm to 11 am.

Agenda: To review and evaluate grant

applications.

Place: Wyndham Garden Hotel—

Pleasanton, 5990 Stoneridge Mall Road,

Pleasanton, CA 94588.

Contact Person: Michael B Small, PhD,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, National

Institutes of Health, 6116 Executive

Boulevard, Room 8040, Bethesda, MD 20892,

301/402–0996.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.392, Cancer Construction,

93.393, Cancer Cause and Prevention

Research; 93.394, Cancer Detection and

Diagnosis Research; 93.395, Cancer

Treatment Research; 93.396, Cancer Biology

Research; 93.397, Cancer Centers Support;

93.398, Cancer Research Manpower; 93.399,

Cancer Control, National Institutes of Health,

HHS)

Dated: May 16, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–12895 Filed 5–22–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as